Qvit, Nir 
; Lin, Amanda J. ; Elezaby, Aly ; Ostberg, Nicolai P. ; Campos, Juliane Cruz ; Ferreira, Julio Cesar Batista ; Rosen, Daria Mochly
Fonte: Pharmaceuticals. Unidade: ICB
Assuntos: ANATOMIA, ISQUEMIA MIOCÁRDICA, TROPONINA I, PROTEÍNAS MUSCULARES, PEPTÍDEOS, INFARTO DO MIOCÁRDIO, CARDIOPATIAS, AMINOÁCIDOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
QVIT, Nir et al. A selective inhibitor of Cardiac Troponin I Phosphorylation by Delta Protein Kinase C (δPKC) as a treatment for Ischemia-reperfusion injury. Pharmaceuticals, v. 15, n. 3, p. 1-11, 2022Tradução . . Disponível em: https://doi.org/10.3390/ph15030271. Acesso em: 15 nov. 2024.APA
Qvit, N., Lin, A. J., Elezaby, A., Ostberg, N. P., Campos, J. C., Ferreira, J. C. B., & Rosen, D. M. (2022). A selective inhibitor of Cardiac Troponin I Phosphorylation by Delta Protein Kinase C (δPKC) as a treatment for Ischemia-reperfusion injury. Pharmaceuticals, 15( 3), 1-11. doi:10.3390/ph15030271NLM
Qvit N, Lin AJ, Elezaby A, Ostberg NP, Campos JC, Ferreira JCB, Rosen DM. A selective inhibitor of Cardiac Troponin I Phosphorylation by Delta Protein Kinase C (δPKC) as a treatment for Ischemia-reperfusion injury [Internet]. Pharmaceuticals. 2022 ; 15( 3): 1-11.[citado 2024 nov. 15 ] Available from: https://doi.org/10.3390/ph15030271Vancouver
Qvit N, Lin AJ, Elezaby A, Ostberg NP, Campos JC, Ferreira JCB, Rosen DM. A selective inhibitor of Cardiac Troponin I Phosphorylation by Delta Protein Kinase C (δPKC) as a treatment for Ischemia-reperfusion injury [Internet]. Pharmaceuticals. 2022 ; 15( 3): 1-11.[citado 2024 nov. 15 ] Available from: https://doi.org/10.3390/ph15030271
